Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion type Assertion NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_head.
- NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion description "[Here we report that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1, BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_provenance.
- NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion evidence source_evidence_literature NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_provenance.
- NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion SIO_000772 21720365 NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_provenance.
- NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion wasDerivedFrom befree-20140225 NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_provenance.
- NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_assertion wasGeneratedBy ECO_0000203 NP608315.RAOU12gjpqiL-Khn9-3Kl4u6W_rc1Vdb952FXhPc92oEM130_provenance.